Hansoh Pharma and Hengrui Pharma Enter into RMB 190 Million Licensing Agreement for SHR6508
Hengrui Pharma
Innovative and High-Quality Pharmaceutical Developer
Hansoh Pharma
Pharmaceutical Research, Production, and Sales
Hansoh Pharma
Innovative Therapeutic Drug Developer
Opportunities to go global have arrived!
![]()
![]()
![]()
European and American pharmaceutical companies are looking for innovative drug products that have been marketed and are in Phase 3 clinical trials for solid tumors, hoping for differentiation and specialization.Long-term benefits,Prioritize the outright purchase of overseas rights!
Interested companies are invited to contact: PharmaTimes BD Team
BD@drugtimes.cn
Opportunities to go global have arrived!![]()
![]()
![]()
European and American pharmaceutical companies are looking for innovative drug products that have been marketed and are in Phase 3 clinical trials for solid tumors, hoping for differentiation and specialization.Long-term benefits,Prioritize the outright purchase of overseas rights!
Interested companies are invited to contact: PharmaTimes BD Team
BD@drugtimes.cn
Opportunities to go global have arrived!
European and American pharmaceutical companies are looking for innovative drug products that have been marketed and are in Phase 3 clinical trials for solid tumors, hoping for differentiation and specialization.Long-term benefits,Prioritize the outright purchase of overseas rights!
The related party transactions between Hengrui Pharma and Hansoh Pharma are not limited to the general scope of commercial cooperation., and has also built a deep-level synergy mechanism. This collaborative model among related companies helps significantly reduce transaction costs and accelerate project progress. Based on the existing trust relationship and highly compatible corporate culture, both parties can communicate and collaborate more smoothly, thereby improving overall operational efficiency and achieving sustainable mutual benefit.
Copyright Statement/Disclaimer
This is a compiled article.
This article is for information exchange purposes only and does not provide any commercial, medical, or investment advice.
The images, videos, fonts, music and other materials in the article are either authorized genuine works purchased by Yaotimes, or from the WeChat public image library, or sourced from the company's official website/network. Some materials are used under the CC0 protocol. All copyrights belong to the respective owners, and Yaotimes makes every effort to acknowledge the sources.
If you have any questions, please contact us.
Sincerely grateful!
DrugTimes Official Website: www.drugtimes.cn
Contact Information:
Phone: 13651980212
WeChat: 27674131
Email: contact@drugtimes.cn
![]()
![]()
![]()
![]()
ClickView more exciting content!
Copyright Statement/Disclaimer
This is a compiled article.
This article is for information exchange purposes only and does not provide any commercial, medical, or investment advice.
The images, videos, fonts, music and other materials in the article are either authorized genuine works purchased by Yaotimes, or from the WeChat public image library, or sourced from the company's official website/network. Some materials are used under the CC0 protocol. All copyrights belong to the respective owners, and Yaotimes makes every effort to acknowledge the sources.
If you have any questions, please contact us.
Sincerely grateful!
DrugTimes Official Website: www.drugtimes.cn
Contact Information:
Phone: 13651980212
WeChat: 27674131
Email: contact@drugtimes.cn
![]()
![]()
![]()
![]()
ClickView more exciting content!
Copyright Statement/Disclaimer
This is a compiled article.
This article is for information exchange purposes only and does not provide any commercial, medical, or investment advice.
The images, videos, fonts, music and other materials in the article are either authorized genuine works purchased by Yaotimes, or from the WeChat public image library, or sourced from the company's official website/network. Some materials are used under the CC0 protocol. All copyrights belong to the respective owners, and Yaotimes makes every effort to acknowledge the sources.
If you have any questions, please contact us.
Sincerely grateful!
DrugTimes Official Website: www.drugtimes.cn
Contact Information:
Phone: 13651980212
WeChat: 27674131
Email: contact@drugtimes.cn